Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The life sciences and medical technology company beat earnings estimates in the third quarter but narrowed its 2022 bioprocessing revenue growth forecast.
Jim Cramer says to buy shares of Danaher on the dip
The life sciences and medical technology company beat earnings estimates in the third quarter but narrowed its 2022 bioprocessing revenue growth forecast.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender